Skip to main content


Reports of anxiety and depression rose to a significant 50% and 44%, respectively, among US residents during the first 9 months of the COVID-19 pandemic, according to study results published online in Translational Behavioral Medicine.
Maternal symptoms of depression and anxiety were among a number of maternal and fetal outcomes that worsened globally during the COVID-19 pandemic, according to a systematic review and meta-analysis.
A history of depression may increase one’s perception of the amount of stress caused by the COVID-19 pandemic in their community, according to a study presented in a poster session at the ADAA 2021 Virtual Conference.
Confirming results from a previous smaller study, researchers found people who reported a history of childhood maltreatment had a more robust response to intravenous (IV) ketamine than other depressed adults seeking ketamine treatment.
Passive unobtrusive smartphone metadata could be used to prospectively predict elevations in mood disorder and depression symptoms, according to studies presented at the American Association for Geriatric Psychiatry 2021 Annual Meeting.
Robin Carhart-Harris, PhD, head of the Centre of Psychedelic Research at Imperial College London in England, discusses the power of psychedelics.
Psych Congress Steering Committee member Charles Raison, MD, discusses heat, including sauna use, as a novel treatment for depression and a tool for improving mental health.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, speaks with general psychiatrist Abbey Strauss, MD, MSW, about the history, chemistry, and potential use of the neurotransmitter…
Back to Top